Answers are grounded in this paper and cite their sources.
Onco-Nephrology, which embodies the unique connection that exists for kidney disease and cancer in clinical medicine, continues to grow by leaps and bounds. The increasing interest in the subfield of Onco-Nephrology is witnessed by the recent conference dedicated to this area that took place in Philadelphia, Pennsylvania, USA. In this issue of the Journal of Onco-Nephrology, a series of papers addressing important topics in this area of subspecialization is presented as part of the Onco-Nephrology Highlights section. These papers are based on some of the lectures delivered at the above-noted Onco-Nephrology Symposium. I hope you find these four papers educational and practical in your provision of care to patients with cancer and kidney disease.
No takes yet. Share an insight, caveat, or question.
Mark A. Perazella (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: